These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1674878)

  • 21. Allelotype of human malignant astrocytoma.
    Fults D; Pedone CA; Thomas GA; White R
    Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.
    Saxena A; Shriml LM; Dean M; Ali IU
    Oncogene; 1999 Feb; 18(6):1385-90. PubMed ID: 10022821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoblastoma gene deletions in human glioblastomas.
    Venter DJ; Bevan KL; Ludwig RL; Riley TE; Jat PS; Thomas DG; Noble MD
    Oncogene; 1991 Mar; 6(3):445-8. PubMed ID: 2011399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity of chromosome 10p in human gliomas.
    Kimmelman AC; Ross DA; Liang BC
    Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular pathogenesis of astrocytoma and glioblastoma multiforme.
    Van de Kelft E
    Acta Neurochir (Wien); 1997; 139(7):589-99. PubMed ID: 9265950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of chromosomal numerical aberration in glioma by FISH (fluorescence in situ hybridization)].
    Kasai H; Imahori T; Kawamoto K
    Hum Cell; 1993 Mar; 6(1):62-5. PubMed ID: 8343450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort.
    Pollack IF; Finkelstein SD; Burnham J; Hamilton RL; Yates AJ; Holmes EJ; Boyett JM; Finlay JL
    Pediatr Neurosurg; 2003 Sep; 39(3):114-21. PubMed ID: 12876389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathways in the formation of gliomas.
    von Deimling A; Louis DN; Wiestler OD
    Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity analysis in malignant gliomas.
    Mizoguchi M; Kuga D; Guan Y; Hata N; Nakamizo A; Yoshimoto K; Sasaki T
    Brain Tumor Pathol; 2011 Jul; 28(3):191-6. PubMed ID: 21629980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alleles in chromosome 10p21-26 in malignant gliomas].
    Oberstrass J; Ring GU; Vogeley KT; Kramm CM; Cobbers JM; Wirths J; Bilzer T; Wechsler W
    Verh Dtsch Ges Pathol; 1994; 78():413-7. PubMed ID: 7534011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP analyses.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Petaña A; Rey JA
    Cancer Genet Cytogenet; 1994 Jan; 72(1):55-8. PubMed ID: 7906611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
    Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
    Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.